VivoSeq
Respiratory

ARDS

0

Pipeline Programs↗

6

Active Trials↗

4

Companies Involved↗

ARDS is an early-stage landscape with 0 programs across 4 companies. The most active players are Bayer, Biotech Pharmaceutical Co., Ltd., RECORDATI GROUP.

Intelligence

Pipeline Metrics

Competitive Density

21/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

8/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Bayer logo

Bayer

0 programs

PreclinicalB

Biotech Pharmaceutical Co., Ltd.

0 programs

PreclinicalR

RECORDATI GROUP

0 programs

PreclinicalTibotec Pharmaceuticals, Ireland logo

Tibotec Pharmaceuticals, Ireland

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

36

clinical trials

Completed22 · 61%
Unknown status5 · 14%
Recruiting5 · 14%
Terminated3 · 8%
Not yet recruiting1 · 3%

Clinical Trials

Trial Activity

36 trials

AEROSOL THERAPY IN ARDS PATIENTS (AERO-IN-ARDS)
Recruiting·TTS Misra Medical College·N/A·NCT07269743·423 enrolled
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
Recruiting·PPPD Development, LP·Phase 2·NCT06701682·200 enrolled
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
Recruiting·PPPD Development, LP·Phase 2·NCT06701669·200 enrolled
Towards Cure Via Only Ultra-short ICB in CSCC
Recruiting·TThe Netherlands Cancer Institute·Phase 2·NCT06823479·41 enrolled
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
Recruiting·PPPD Development, LP·Phase 2·NCT06703073·600 enrolled
MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients
Not yet recruiting·MMedRegen LLC·Phase 2·NCT06308926·60 enrolled
Bioavailability of Dienogest and Ethinyl Estradiol Tablets 2.0 mg/0.03 mg With Regards to Reference Product
Completed·LLaboratorios Andromaco S.A.·Phase 1·NCT04193852·10 enrolled
Bioavailability of Oseltamivir Phosphate 75 mg With Regards to Reference Product
Completed·LLaboratorios Andromaco S.A.·Phase 1·NCT05083325·36 enrolled
Clinical Study Investigating the Conversion of the Contraceptive Compound Norethisterone Within the Body Towards the Contraceptive Compound Ethinylestradiol
Completed·Bayer logoBayer·Phase 1·NCT02170038·16 enrolled
Assessment of 2012 Bioequivalence Standards for Warfarin
Completed·UUniversity of California, San Francisco·Phase 1·NCT02574754·10 enrolled
Roflumilast as add-on Therapy in Early Cases of ARDS
Completed·—·Phase 2·NCT04744090·76 enrolled
Bioavailability of Diosmin/Hesperidin (90/10) 500 mg Tablets With Regards to Reference Product
Completed·LLaboratorios Andromaco S.A.·Phase 1·NCT05158192·12 enrolled
Early Insulin and Development of ARDS
Completed·—·Phase 2·NCT00605696·18 enrolled
Bioavailability of Levonorgestrel and Ethinyl Estradiol Tablets 15.0 mg/0.03 mg With Regards to Reference Product
Completed·LLaboratorios Andromaco S.A.·Phase 1·NCT05282940·36 enrolled
Bioavailability of Desogestrel 0.075 mg Tablets With Regards to Reference Product
Completed·LLaboratorios Andromaco S.A.·Phase 1·NCT04422028·30 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)